Tumor angiogenesis: causes, consequences, challenges and opportunities
R Lugano, M Ramachandran, A Dimberg - Cellular and Molecular Life …, 2020 - Springer
Tumor vascularization occurs through several distinct biological processes, which not only
vary between tumor type and anatomic location, but also occur simultaneously within the …
vary between tumor type and anatomic location, but also occur simultaneously within the …
The role of apelin in cardiovascular diseases, obesity and cancer
MB Wysocka, K Pietraszek-Gremplewicz… - Frontiers in …, 2018 - frontiersin.org
Apelin is an endogenous peptide identified as a ligand of the G protein-coupled receptor
APJ. Apelin belongs to the family of adipokines, which are bioactive mediators released by …
APJ. Apelin belongs to the family of adipokines, which are bioactive mediators released by …
Apelin in disease
H Antushevich, M Wójcik - Clinica chimica acta, 2018 - Elsevier
Apelin, a regulatory peptide, is a ligand of the APJ receptor that belongs to the G protein-
coupled receptor family. Apelin and APJ are widely distributed in the body and play potential …
coupled receptor family. Apelin and APJ are widely distributed in the body and play potential …
Role of Apelin/APJ axis in cancer development and progression
J Masoumi, A Jafarzadeh, H Khorramdelazad… - Advances in medical …, 2020 - Elsevier
Apelin is an endogenous peptide, which is expressed in a vast board of organs such as the
brain, placenta, heart, lungs, kidneys, pancreas, testis, prostate and adipose tissues. The …
brain, placenta, heart, lungs, kidneys, pancreas, testis, prostate and adipose tissues. The …
The Apelin–Apelin receptor axis triggers cholangiocyte proliferation and liver fibrosis during mouse models of cholestasis
Background and Aims Apelin (APLN) is the endogenous ligand of its G protein–coupled
receptor, apelin receptor (APJ). APLN serum levels are increased in human liver diseases …
receptor, apelin receptor (APJ). APLN serum levels are increased in human liver diseases …
[HTML][HTML] Apelin promotes osteosarcoma metastasis by upregulating PLOD2 expression via the Hippo signaling pathway and hsa_circ_0000004/miR-1303 axis
NTN Trang, CY Lai, HC Tsai, YL Huang… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Osteosarcoma is a highly mortal bone tumor, with a high metastatic potential, promoted in
part by the enzyme procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2). Increasing …
part by the enzyme procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2). Increasing …
Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway
Y Wang, H Yu, X Xie, T Deng, L Ye, L Wu, X Ding… - Oncogene, 2021 - nature.com
Cholangiocarcinoma (CCA) is aggressive and has poor clinical outcomes because of
typically delayed diagnosis and a lack of effective non-surgical therapeutic options. Recent …
typically delayed diagnosis and a lack of effective non-surgical therapeutic options. Recent …
Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target
J Chen, Z Li, Q Zhao, L Chen - Journal of Cellular Physiology, 2022 - Wiley Online Library
Cancer is a disease that seriously endangers human health and is mainly characterized by
a high metastasis rate, a high recurrence rate, and a high mortality rate. The treatment of …
a high metastasis rate, a high recurrence rate, and a high mortality rate. The treatment of …
Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications
P Chatterjee, M Gheblawi, K Wang, J Vu… - Clinical …, 2020 - portlandpress.com
The apelinergic system is widely expressed and acts through autocrine and paracrine
signaling to exert protective effects, including vasodilatory, metabolic, and inotropic effects …
signaling to exert protective effects, including vasodilatory, metabolic, and inotropic effects …
Research progress on mechanism of neuroprotective roles of Apelin-13 in prevention and treatment of Alzheimer's disease
T Wan, M Fu, Y Jiang, W Jiang, P Li, S Zhou - Neurochemical research, 2022 - Springer
Alzheimer's disease (AD) is the most common type of dementia. Currently, more than 50
million people live with dementia worldwide, and this number is expected to increase. Some …
million people live with dementia worldwide, and this number is expected to increase. Some …